You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Jazz Pharmaceuticals

Continue reading below

The maker of the narcolepsy medicine Xyrem rose on its deal to buy EUSA Pharma Inc. for $650 million to diversify its drug holdings, including a therapy for leukemia. Acquiring closely held EUSA, based in Langhorne, Pa., will immediately add to earnings, Dublin-based Jazz said, and increase 2013 revenue by $210 million to $230 million. EUSA posted first-quarter net sales of $46 million.

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week